Myocardial infarction, the number one cause of sudden death in adults and the number two cause of death in Korea, is a deadly disease with an initial mortality rate of 30%, and about 5%–10% of patients die even if they are transported to a medical center for treatment.
Click here for original story, Novel treatment for myocardial infarction uses nanovesicles to modulate immune response
Source: Phys.org